Neurocrine Bioscience buy Barclays PLC
Start price
02.05.24
/
50%
€131.25
Target price
02.05.25
€157.54
Performance (%)
-17.79%
Price
22:26
€107.90
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -17.79%. This prediction currently runs until 02.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -2.132% | -2.132% |
iShares Core DAX® | 1.510% | 2.268% |
iShares Nasdaq 100 | -0.271% | -1.533% |
iShares Nikkei 225® | -0.108% | 0.411% |
iShares S&P 500 | 0.479% | 0.563% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $150.00 to $169.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€109.95
09.09.24
09.09.24
€144.91
09.09.25
09.09.25
-1.86%
22:26
22:26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.00
02.08.24
02.08.24
€164.74
02.08.25
02.08.25
-22.37%
22:26
22:26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
-16.45%
22:26
22:26